Saltar al contenido
Merck

Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway.

Immunology (2014-07-06)
Jennifer C Bailey, Abhirami K Iyer, Gourapura J Renukaradhya, Yinling Lin, Hoa Nguyen, Randy R Brutkiewicz
RESUMEN

CD1d-mediated lipid antigen presentation activates a subset of innate immune lymphocytes called invariant natural killer T (NKT) cells that, by virtue of their potent cytokine production, bridge the innate and adaptive immune systems. Transforming growth factor (TGF-β) is a known immune modulator that can activate the mitogen-activated protein kinase p38; we have previously shown that p38 is a negative regulator of CD1d-mediated antigen presentation. Several studies implicate a role for TGF-β in the activation of p38. Therefore, we hypothesized that TGF-β would impair antigen presentation by CD1d. Indeed, a dose-dependent decrease in CD1d-mediated antigen presentation and impairment of lipid antigen processing was observed in response to TGF-β treatment. However, it was found that this inhibition was not through p38 activation. Instead, Smads 2, 3 and 4, downstream elements of the TGF-β canonical signalling pathway, contributed to the observed effects. In marked contrast to that observed with CD1d, TGF-β was found to enhance MHC class II-mediated antigen presentation. Overall, these results suggest that the canonical TGF-β/Smad pathway negatively regulates an important arm of the host's innate immune responses - CD1d-mediated lipid antigen presentation to NKT cells.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Glicerol, ACS reagent, ≥99.5%
Sigma-Aldrich
Glicerol, for molecular biology, ≥99.0%
Sigma-Aldrich
Glicerol, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
2- Mercaptoetanol, for molecular biology, suitable for electrophoresis, suitable for cell culture, BioReagent, 99% (GC/titration)
Sigma-Aldrich
2- Mercaptoetanol, ≥99.0%
Sigma-Aldrich
2- Mercaptoetanol, BioUltra, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
Glicerol solution, 83.5-89.5% (T)
Sigma-Aldrich
Glicerol, BioUltra, for molecular biology, anhydrous, ≥99.5% (GC)
Sigma-Aldrich
Glicerol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
Glicerol, puriss., anhydrous, 99.0-101.0% (alkalimetric)
USP
Glicerol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Glicerol, ≥99.5%
Sigma-Aldrich
Glicerol, FCC, FG
Sigma-Aldrich
Glicerol, puriss. p.a., ACS reagent, anhydrous, dist., ≥99.5% (GC)
Supelco
Glicerol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glicerol, BioXtra, ≥99% (GC)
Sigma-Aldrich
Glicerol solution, puriss., meets analytical specification of Ph. Eur., BP, 84-88%
Sigma-Aldrich
Glicerol, meets USP testing specifications
Sigma-Aldrich
Glicerol, SAJ first grade, ≥98.0%
Sigma-Aldrich
Glicerol, JIS special grade, ≥99.0%
Supelco
Glicerol, analytical standard
Supelco
2- Mercaptoetanol, for HPLC derivatization, LiChropur, ≥99.0% (GC)
Sigma-Aldrich
Glicerol, tested according to Ph. Eur., anhydrous
Sigma-Aldrich
2- Mercaptoetanol, ≥99.0%
Sigma-Aldrich
2- Mercaptoetanol, SAJ special grade, ≥99.0%
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Smad4
Sigma-Aldrich
MISSION® esiRNA, targeting human SMAD4